The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	izad144
Journal	Inflammatory Bowel Diseases
DOIs	https://doi.org/10.1093/ibd/izad144
Publication status	E-pub ahead of print - 31-Jul-2023

Access to Document

The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Final publisher's version, 102 KB
Licence: Taverne
Embargo ends: 31/01/2024
Request copy

@article{d976b04235b049d3bb2b4273a585a36c,

title = "The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients",

author = "Otten, {Antonius T.} and Gerard Dijkstra and Visschedijk, {Marijn C.} and Bourgonje, {Arno R.}",

year = "2023",

month = jul,

day = "31",

doi = "10.1093/ibd/izad144",

language = "English",

journal = "Inflammatory Bowel Diseases",

issn = "1078-0998",

publisher = "LIPPINCOTT WILLIAMS & WILKINS",

}

TY - JOUR

T1 - The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease

T2 - An Emphasis on the Essential Ingredients

AU - Otten, Antonius T.

AU - Dijkstra, Gerard

AU - Visschedijk, Marijn C.

AU - Bourgonje, Arno R.

PY - 2023/7/31

Y1 - 2023/7/31

U2 - 10.1093/ibd/izad144

DO - 10.1093/ibd/izad144

M3 - Comment/Letter to the editor

C2 - 37523671

SN - 1078-0998

JO - Inflammatory Bowel Diseases

JF - Inflammatory Bowel Diseases

M1 - izad144

ER -